Cabozantinib (XL184) Inhibits Growth and Invasion of Preclinical TNBC Models

PURPOSE: Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype that is associated with poor clinical outcome. There is a vital need for effective targeted therapeutics for TNBC patients, yet treatment strategies are challenged by the significant intertumoral heterogeneity withi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Cancer Res
Autors principals: Sameni, Mansoureh, Tovar, Elizabeth A., Essenburg, Curt J., Chalasani, Anita, Linklater, Erik S., Borgman, Andrew, Cherba, David M., Anbalagan, Arulselvi, Winn, Mary E., Graveel, Carrie R., Sloane, Bonnie F.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5500174/
https://ncbi.nlm.nih.gov/pubmed/26432786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-15-0187
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars